Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Orca-T Results in High Gvhd-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies: Results of a Single Center Phase 2 and a Multicenter Phase 1b Study

Blood (2021) 138 (Supplement 1): 98.

https://doi.org/10.1182/blood-2021-154191

Published: 2021

Journal Articles

Orca-T, a Precision Treg-Engineered Donor Product, Prevents Acute Gvhd with Less Immunosuppression in an Early Multicenter Experience with Myeloablative HLA-Matched Transplants

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-142974

Published: 2020

Journal Articles

Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

Blood (2012) 120 (18): 3635–3646.

https://doi.org/10.1182/blood-2012-02-400937

Published: 2012

Includes: Supplemental data

Journal Articles

Generation of HIV Resistant and Functional Macrophages From Hematopoietic Stem Cell Derived Induced Pluripotent Stem Cells

Amal Kambal, MS, Gaela Mitchell, Whitney Cary, William Gruenloh, Yunjoon Jung, Catherine Nacey, Stefanos Kalomoiris, Matt Lindsey, Gerhard Bauer, Jan A. Nolta, PhD, Joseph S. Anderson, PhD

Blood (2010) 116 (21): 562.

https://doi.org/10.1182/blood.V116.21.562.562

Published: 2010

Journal Articles

Evaluating the Safety and Efficacy of Anti-HIV Transgenic Cells in a Humanized Mouse Model (NOD/SCIDγ c −/− ) for HIV Stem Cell Gene Therapy.

Joseph S. Anderson, Ph.D., Jon Walker, Louisa Wirthlin, John Javien, Jan A. Nolta, Ph.D., Gerhard Bauer

Blood (2008) 112 (11): 2352.

https://doi.org/10.1182/blood.V112.11.2352.2352

Published: 2008

Journal Articles

In Vivo Biosafety Model To Assess Risk of Adverse Events from Retroviral and Lentiviral Vectors.

Gerhard Bauer, Mo Dao, Ph.D., Scott Case, Ph.D., Todd Meyerrose, Ph.D., Louisa Wirthlin, Phillip Herrbrich, Ph.D., Ping Zhou, Ph.D., Xiuli Wang, Ph.D., Susie Csik, Jesusa Arevalo, Dianne Skelton, Jon Walker, Karen Pepper, Gay Crooks, MD, Donald Kohn, MD, Jan Nolta, Ph.D.

Blood (2007) 110 (11): 2595.

https://doi.org/10.1182/blood.V110.11.2595.2595

Published: 2007

Journal Articles

Adult Human Stem Cells Exert Therapeutic Effects To Repair Damaged Tissues in Xenograft Systems through Secretion of Trophic Factors Rather Than Direct Incorporation and Expansion.

Claus Sondergaard, PhD, David Hess, Ph.D., Ivana Rosova, Sarah Hohm, Louisa Wirthlin, Ryan Lahey, Matt Lindsey, Jon Walker, Gerhard Bauer, Ping Zhou, Ph.D., Jan Nolta, Ph.D.

Blood (2007) 110 (11): 3693.

https://doi.org/10.1182/blood.V110.11.3693.3693

Published: 2007

Journal Articles

In Vivo Bioluminescence Imaging (BLI) and Sequential 18 F]FHBG microPET Imaging Studies of Human T Cell (huT) Trafficking, Expansion and Xenogeneic Graft-Versus-Host-Disease (XGVHD) Following Different Routes of T Cell Administration.

Bruno Nervi, MD, Michael P. Rettig, PhD, Julie K. Ritchey, Hanlin L. Wang, MD,PhD, Gerhard Bauer, Jon Walker, Julie L. Prior, David Piwnica-Worms, MD,PhD, Jan A. Nolta, PhD, John F. DiPersio, MD,PhD

Blood (2006) 108 (11): 5178.

https://doi.org/10.1182/blood.V108.11.5178.5178

Published: 2006

Journal Articles

Naive and Ex Vivo Activated Human T Cells Generate Consistent Engraftment and Lethal Graft-Versus-Host Disease (GvHD) in NOD SCID β 2M Null Mice: A New Xenogeneic Model for GvHD.

Bruno Nervi, MD, Michael P. Rettig, PhD, Julie K. Ritchey, Gerhard Bauer, Jon Walker, Dave Hess, PhD, Phillip E. Herrbrich, Mark Bonyhadi, PhD, Ronald J. Berenson, MD, Jan A. Nolta, PhD, John F. DiPersio, MD, PhD

Blood (2005) 106 (11): 3106.

https://doi.org/10.1182/blood.V106.11.3106.3106

Published: 2005

Journal Articles

Large Scale Ex Vivo GMP Expanded, Activated Human T Cells Consistently Induce Lethal GvHD in a Mouse Xenotransplant Model - A New Way To Study Treatments for Acute GvHD.

Gerhard Bauer, Jon Walker, Bruno Nervi, Julie Ritchey, Jackie Hughes, Bill Eades, Mark Bonyhadi, Jan Nolta, John F. DiPersio

Blood (2005) 106 (11): 5242.

https://doi.org/10.1182/blood.V106.11.5242.5242

Published: 2005

Journal Articles

A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease.

Bruno Nervi, MD, Michael Rettig, PhD, Julie Ritchey, Jon Walker, Gerhard Bauer, Phillip Herrbrich, Jan A. Nolta, PhD, John F. DiPersio, Md/PhD

Blood (2004) 104 (11): 4977.

https://doi.org/10.1182/blood.V104.11.4977.4977

Published: 2004

Journal Articles

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

Bruno Nervi, MD, Michael Rettig, PhD, Julie Ritchey, Jon Walker, Gerhard Bauer, Philip Herrbrich, Mark L. Bonyhadi, PhD, Jan A. Nolta, PhD, John F. DiPersio, MD/PhD

Blood (2004) 104 (11): 4979.

https://doi.org/10.1182/blood.V104.11.4979.4979

Published: 2004

Journal Articles

GMP Scale up for a Clinical Gene Therapy Trial - High Efficiency Human T Cell Expansion and Transduction in a Closed Culture System Utilizing Serumfree Medium and Low IL-2 Concentrations.

Gerhard Bauer, Jon E. Walker, Julie Ritchey, Jan A. Nolta, John F. DiPersio

Blood (2004) 104 (11): 5250.

https://doi.org/10.1182/blood.V104.11.5250.5250

Published: 2004

Journal Articles

High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

Francois Moreau-Gaudry, Ping Xia, Gang Jiang, Natalya P. Perelman, Gerhard Bauer, James Ellis, Katherine H. Surinya, Fulvio Mavilio, Che-Kun Shen, Punam Malik

Blood (2001) 98 (9): 2664–2672.

https://doi.org/10.1182/blood.V98.9.2664

Published: 2001

Journal Articles

A Clinical Trial of Retroviral-Mediated Transfer of a rev -Responsive Element Decoy Gene Into CD34 + Cells From the Bone Marrow of Human Immunodeficiency Virus-1–Infected Children

Donald B. Kohn, Gerhard Bauer, C. Robert Rice, J.C. Rothschild, Denise A. Carbonaro, Penelope Valdez, Qian-lin Hao, Chen Zhou, Ingrid Bahner, Karen Kearns, Kate Brody, Sarah Fox, Elizabeth Haden, Kathy Wilson, Cathy Salata, Cathy Dolan, Charles Wetter, Estuardo Aguilar-Cordova, Joseph Church

Blood (1999) 94 (1): 368–371.

https://doi.org/10.1182/blood.V94.1.368.413a47_368_371

Published: 1999

Journal Articles

Inhibition of Human Immunodeficiency Virus-1 (HIV-1) Replication After Transduction of Granulocyte Colony-Stimulating Factor–Mobilized CD34 + Cells From HIV-1–Infected Donors Using Retroviral Vectors Containing Anti–HIV-1 Genes

Gerhard Bauer, Penelope Valdez, Karen Kearns, Ingrid Bahner, Sui Fang Wen, John A. Zaia, Donald B. Kohn

Blood (1997) 89 (7): 2259–2267.

https://doi.org/10.1182/blood.V89.7.2259

Published: 1997

NARROW

Orca-T Results in High Gvhd-Free and Relapse-Free Survival Following Myeloablative Conditioning for Hematological Malignancies: Results of a Single Center Phase 2 and a Multicenter Phase 1b Study

Orca-T, a Precision Treg-Engineered Donor Product, Prevents Acute Gvhd with Less Immunosuppression in an Early Multicenter Experience with Myeloablative HLA-Matched Transplants

Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

Generation of HIV Resistant and Functional Macrophages From Hematopoietic Stem Cell Derived Induced Pluripotent Stem Cells

Evaluating the Safety and Efficacy of Anti-HIV Transgenic Cells in a Humanized Mouse Model (NOD/SCIDγ c −/− ) for HIV Stem Cell Gene Therapy.

In Vivo Biosafety Model To Assess Risk of Adverse Events from Retroviral and Lentiviral Vectors.

Adult Human Stem Cells Exert Therapeutic Effects To Repair Damaged Tissues in Xenograft Systems through Secretion of Trophic Factors Rather Than Direct Incorporation and Expansion.

In Vivo Bioluminescence Imaging (BLI) and Sequential 18 F]FHBG microPET Imaging Studies of Human T Cell (huT) Trafficking, Expansion and Xenogeneic Graft-Versus-Host-Disease (XGVHD) Following Different Routes of T Cell Administration.

Naive and Ex Vivo Activated Human T Cells Generate Consistent Engraftment and Lethal Graft-Versus-Host Disease (GvHD) in NOD SCID β 2M Null Mice: A New Xenogeneic Model for GvHD.

Large Scale Ex Vivo GMP Expanded, Activated Human T Cells Consistently Induce Lethal GvHD in a Mouse Xenotransplant Model - A New Way To Study Treatments for Acute GvHD.

A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease.

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

GMP Scale up for a Clinical Gene Therapy Trial - High Efficiency Human T Cell Expansion and Transduction in a Closed Culture System Utilizing Serumfree Medium and Low IL-2 Concentrations.

High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

A Clinical Trial of Retroviral-Mediated Transfer of a rev -Responsive Element Decoy Gene Into CD34 + Cells From the Bone Marrow of Human Immunodeficiency Virus-1–Infected Children

Inhibition of Human Immunodeficiency Virus-1 (HIV-1) Replication After Transduction of Granulocyte Colony-Stimulating Factor–Mobilized CD34 + Cells From HIV-1–Infected Donors Using Retroviral Vectors Containing Anti–HIV-1 Genes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only